Patient-reported quality of life (QoL) was similar between proton beam therapy (PBT) and intensity-modulated radiation ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

United Kingdom-based biopharmaceutical giant AstraZeneca will add 10 to 15 new projects to the company's research and ...

Shares of AstraZeneca PLC AZN inched down 0.57% to £115.88 Monday, on what proved to be an all-around grim trading session ...

….Link noted a broadening market trend over the past couple of months, indicating that while tech has taken the lead, other ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Dr Sanjeev Panchal, Country President and MD, AstraZeneca India, stated company's mission to bring innovative medicine faster ...

The FDA has approved a nasal spray flu vaccine for home use. Here's how it works, and when it will be available.

Knowles' journey began nearly five years ago when, in a moment of keen self-awareness that would make headlines.

Mavacamten had been FDA approved on the basis of the EXPLORER-HCM trial's finding that the drug resulted in better functional ...

The FDA has approved a nasal spray flu vaccine for home use. Here's how it works, and when it will be available.

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...